Nurix Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Brisbane, CA
NRIX chart
What traders are saying about $NRIX
Latest postsNurix Therapeutics, Inc. news
- Could You Have Seen The Run In Kymera Stock Coming?
trefis.com ·
- Oppenheimer's top 50 small- and mid-cap Buy list
TradingView ·
- Nurix Therapeutics Stock Price Forecast. Should You Buy NRIX?
StockInvest.us ·
- Nurix Therapeutics, Inc. Estimates – NASDAQ:NRIX
TradingView ·
- Responsive Playbooks and the NRIX Inflection
Stock Traders Daily ·
- Nurix Therapeutics, Inc. (NRIX) - What Are Researchers Thinking About This Stock?
MarketBeat ·
- Nurix stock: H.C. Wainwright raises target for Nurix stock to USD 36.00
ad-hoc-news.de ·
- Is Earnings Swing Altering The Investment Case For Nurix Therapeutics Stock (NRIX)?
Simply Wall Street ·
- Roche's 9M 2026 Sales Rise on Strong Drug Demand, Pipeline Advances
Yahoo Finance ·
- What Nurix Therapeutics Stock's Profit Turnaround Means For Shareholders
Yahoo Finance ·
- Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth?
Yahoo Finance ·
- Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
Yahoo Finance ·
Nurix Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $84.0M | $54.5M | $77.0M | $38.6M |
| Net income | -$264.5M | -$193.6M | -$143.9M | -$180.4M |
| Diluted EPS | $-3.05 | $-2.88 | $-2.65 | $-3.71 |
| Total assets (year end) | $688.1M | $669.3M | $355.6M | $416.8M |
| Cash and equivalents (year end) | $247.0M | $110.0M | $54.6M | $64.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nurix Therapeutics, Inc.
- Ticker
- NRIX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Brisbane, CA
- Incorporated in
- DE
- Fiscal year end
- November 30
- SEC CIK
- 1549595
- Former names
- Nurix, Inc.
Frequently asked questions
What exchange is Nurix Therapeutics, Inc. listed on?
Nurix Therapeutics, Inc. trades on the Nasdaq under the ticker symbol NRIX.
What industry is Nurix Therapeutics, Inc. in?
Nurix Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nurix Therapeutics, Inc. headquartered?
Nurix Therapeutics, Inc.'s business address on file with the SEC is in Brisbane, CA.
When does Nurix Therapeutics, Inc.'s fiscal year end?
Nurix Therapeutics, Inc.'s fiscal year ends on November 30.
How much revenue did Nurix Therapeutics, Inc. report?
Nurix Therapeutics, Inc. reported $84.0M in revenue for calendar year 2025, according to its SEC filings.